HomeNMRA • NASDAQ
add
Neumora Therapeutics Inc
Previous close
$2.28
Day range
$2.21 - $2.30
Year range
$0.61 - $11.57
Market cap
365.04M USD
Avg Volume
2.81M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 52.70M | -31.24% |
Net income | -56.76M | 21.77% |
Net profit margin | — | — |
Earnings per share | -0.35 | 22.22% |
EBITDA | -52.68M | 31.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 171.52M | -49.74% |
Total assets | 177.83M | -49.56% |
Total liabilities | 45.67M | 43.63% |
Total equity | 132.16M | — |
Shares outstanding | 167.09M | — |
Price to book | 2.77 | — |
Return on assets | -65.60% | — |
Return on capital | -74.21% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -56.76M | 21.77% |
Cash from operations | -46.63M | -39.27% |
Cash from investing | 51.32M | -67.31% |
Cash from financing | -136.00K | -108.88% |
Net change in cash | 4.55M | -96.36% |
Free cash flow | -23.05M | -157.78% |
About
Founded
2019
Headquarters
Website
Employees
95
